Option chain shows key data for Sinopharm Gr Co's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Sinopharm Gr Co.

Sinopharm Gr Co (OTC:SHTDF) Stock, Option Chain

Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2023. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.

Biotech

News

Global

Media

General

BNTX

MRNA

SHTDF

SHTDY

China&#39;s Sinopharm Group (OTC: SHTDY) said Wednesday its COVID-19 vaccine candidate BBIBP-CorV — developed in partnership with Beijing Biological Products Institute Co.

China&#39;s Sinopharm COVID-19 Vaccine Shows 79.34% Efficacy

SINOPHARM GROUP CO LTD by Sinopharm Group Co. Ltd.

Comments

Sinopharm Gr Co

Sinopharm Gr Co (SHTDF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga